Both GLP #1 and GLP #2 were originally developed for diabetes management through weight loss
Liraglutide improves blood sugar levels by creating similar effects in the body as GLP-1 in the pancreas, which is often found in insufficient levels in those with type 2 diabetes
Genetic predispositions in appetite regulation, insulin sensitivity, and metabolic response to certain medications can significantly influence outcomes
However, a proactive approach to potential long-term effects, especially bone health concerns, is essential for maximizing these benefits while protecting your overall health
Thus, the growth in GLP-1 RA prescribing among patients with PCOS may reflect a combination of general expansion in GLP-1 RA use and the high prevalence of metabolic indications in this population
Nanofat, on the other hand, has been micronized and enriched, like platelet-rich plasma, to eliminate living cells and acts more like a biostimulatory matrix to improve skin quality and address sub cutaneous fat loss. For patients taking GLP-1 drugs, autologous fat transfer is Rameshs go-to choice for volume restoration
